Inhibition of translocator protein 18 kDa suppressed the progression of glioma via the ELAV-like RNA-binding protein 1/MAPK-activated protein kinase 3 axis-Reference-Cited by-同舟云学术

Inhibition of translocator protein 18 kDa suppressed the progression of glioma via the ELAV-like RNA-binding protein 1/MAPK-activated protein kinase 3 axis

Published:2022-03-01 Issue:3 Volume:13 Page:7457-7470
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Wang Jingya¹²³,Ren Peng¹^ORCID,Zeng Zhirui³,Ma Li¹,Li Yunjun⁴,Zhang Hongmei²^ORCID,Guo Wenzhi¹

Affiliation:

1. Department of Anesthesiology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, Dongcheng,China

2. Department of Gastroenterology, The Affiliated Hospital of Weifang Medical University, Weifang, Shandong, China

3. Guizhou Provincial Key Laboratory of Pathogenesis & Drug Research on Common Chronic Diseases, Department of Physiology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China

4. Department of Neurosurgery, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, Dongcheng, China

Funder

PLA Youth Training Project for Medical Science

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2048992

Reference37 articles.

1. Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition

2. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis